Detalhe da pesquisa
1.
Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities.
Mol Cell Proteomics
; 21(2): 100182, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922008
2.
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies.
Trends Immunol
; 39(3): 209-221, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29275092
3.
Quantitative Proteome Responses to Oncolytic Reovirus in GM-CSF- and M-CSF-Differentiated Bone Marrow-Derived Cells.
J Proteome Res
; 19(2): 708-718, 2020 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31884793
4.
Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy.
J Proteome Res
; 18(6): 2666-2675, 2019 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31095916
5.
Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin.
Anal Chem
; 91(8): 5106-5115, 2019 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30779550
6.
Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion.
Stem Cells
; 36(5): 641-654, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29341428
7.
MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies.
J Proteome Res
; 16(4): 1806-1816, 2017 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28244318
8.
Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages.
J Proteome Res
; 16(9): 3391-3406, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28768414
9.
Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus.
J Immunol
; 194(9): 4397-412, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25825443
10.
NAD+ salvage pathway in cancer metabolism and therapy.
Pharmacol Res
; 114: 274-283, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27816507
11.
After virus exposure, early bystander naïve CD8 T cell activation relies on NAD+ salvage metabolism.
Front Immunol
; 13: 1047661, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36818473
12.
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma.
J Exp Med
; 218(10)2021 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34495298
13.
Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
Oncoimmunology
; 9(1): 1794424, 2020 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923158
14.
Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic Reovirus.
Cancer Res
; 79(15): 3824-3836, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31088833
15.
Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis.
Acta Neuropathol Commun
; 6(1): 4, 2018 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301568
16.
The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis.
Cell Rep
; 24(9): 2381-2391.e5, 2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30157431
17.
Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines.
Front Immunol
; 8: 800, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751892
18.
Autophagic homeostasis is required for the pluripotency of cancer stem cells.
Autophagy
; 13(2): 264-284, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27929731
19.
All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy.
Oncoimmunology
; 5(1): e1057674, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26942069
20.
Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy.
Viruses
; 7(12): 6506-25, 2015 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26690204